These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 14949095

  • 1. Chemotherapeutic activity of 6-sulfanilamido-2,4-dimethylpyrimidine (elkosin).
    EISMAN PC, GEFTIC SG, LIGENZOWSKI F, MAYER RL.
    Proc Soc Exp Biol Med; 1952 Jul; 80(3):493-5. PubMed ID: 14949095
    [No Abstract] [Full Text] [Related]

  • 2. [Experimental and clinical experiences with elkosin, 6-sulfanilamido-2-4-dimethylpyrimidine].
    PREUSS HG.
    Munch Med Wochenschr; 1950 Nov 10; 92(31-32):1301-5. PubMed ID: 14796609
    [No Abstract] [Full Text] [Related]

  • 3. Chemotherapeutic studies with 2, 4-dimethoxy-6-sulfanilamido-1, 3-diazine (madribon).
    SCHNITZER RJ, DELORENZO WF, GRUNBERG E, RUSSOMANNO R.
    Proc Soc Exp Biol Med; 1958 Nov 10; 99(2):421-4. PubMed ID: 13601890
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Experimental studies on the effect of elkosin on the H2S splitting by Escherichia coli bacteria].
    TANNERT S.
    Z Gesamte Inn Med; 1952 Nov 15; 7(22):1042-6. PubMed ID: 13039339
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparative oral toxicity of 6-sulphonamido-2,4-dimethylpyrimidine (elkosin) and of various sulphonamide combinations.
    TRIPOD J.
    Arch Int Pharmacodyn Ther; 1953 Jul 15; 94(3):338-45. PubMed ID: 13093052
    [No Abstract] [Full Text] [Related]

  • 10. Therapy with a new sulfonamide triple mixture; sulfadiazine, sulfamerazine, elkosin.
    LEHR D, TERRANOVA R, BLUMENFELD S, GOLDFARB ML.
    Postgrad Med; 1953 Mar 15; 13(3):231-38. PubMed ID: 13037579
    [No Abstract] [Full Text] [Related]

  • 11. An evaluation of elkosin, gantrisin and sulfacetamide in standardized infections in mice.
    WHITE HJ, WADSWORTH BC, REDIN GS, GENTILE AJ.
    Antibiot Chemother (Northfield); 1952 Dec 15; 2(12):659-77. PubMed ID: 24542157
    [No Abstract] [Full Text] [Related]

  • 12. Observations on absorption, distribution, and excretion of elkosin (N-[2,6-dimethyl-4-pyrimidyl]-sulfanilamide) in man.
    PRIOR JA, SASLAW S.
    J Lab Clin Med; 1951 Sep 15; 38(3):420-7. PubMed ID: 14880757
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of antibacterial activity of single and combined sulfonamides.
    WEINSTEIN L, MURPHY EB.
    Proc Soc Exp Biol Med; 1952 Jul 15; 80(3):519-22. PubMed ID: 14949105
    [No Abstract] [Full Text] [Related]

  • 20. [New sulfonamide preparations (elkosin, aristamid, mefenal)].
    GRUNKE W.
    Ther Ggw; 1951 Nov 15; 90(11):411-5. PubMed ID: 14893235
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.